Advertisement · 728 × 90
#
Hashtag
#dapackd
Advertisement · 728 × 90
Post image

It take 2 to tango. Cardio-Renal benefits of flozins.
#EMPPEROR #DAPACKD #Flozinate #SGLT2i
www.kidney-international.org/action/showPdf

0 0 0 0
Post image Post image Post image Post image

@eraedta 1st #eseminar happening now! Hiddo Heerspink on all things #SGLT2i they are proximal diuretics but with lots of additional benefits🤩...tune in now #dapackd featuring now @ChristophWanne4 @Giusepp79923064 @JuanCarlosAlmi YouTube later if you can’t come now 👆🏻🎉

0 0 0 0
Post image

Physician-Scientist @NU_Nephrology. Adult beverage game at Casa Lin tonight: take a sip of sparking rosé when someone says tubuloglomerular feedback, mitochondria, or apple (HT @ssfarouk).

No COI for this chat. #NephJC #DAPACKD

0 0 0 0
Post image

Big reduction in all cause mortality
#ESCCongress #dapackd

0 0 0 0

Regarding #sglt2i as more than glucose-lowering drugs: "Maybe we should stop thinking in boxes, not even outside of the box, but without boxes. Maybe we should be thinking in terms of organ protection."

#DAPACKD #ESCCongress

0 0 0 0

Indeed, as we suspected, it's not all about the sugar. #betablocker for the kidney, with survival advantage rooted in shift of energy utilization?

Great question by moderator: did issues in classification of death complicate analysis of CVD mortality?

#DAPACKD #ESCCongress

0 0 1 0
Post image

Look at that NNT!
#ESCCongress #dapackd

0 0 0 0

No major differences in adverse effects between drug and placebo groups. Also no DKA or hypoglycemic events.

#DAPACKD #ESCCongress

0 0 1 0

#DAPACKD primary outcome of dapa's benefit in CKD was consistent in patients with AND without diabetes

#ESCCongress

0 0 1 0

#DAPACKD primary outcome: Look at that p value!

#ESCCongress

0 0 1 0